MTXMinerals Technologies Inc.
The Read
MTX's stock historically showed a median absolute move of ~1%.
The schedule
- Thu22Oct
Key Q3 financial print to lock in full-year expectations, beginning at $78.00.
- Sun15Nov
Credit rating affirmation amidst higher-for-longer interest rates, opening at $82.00.
- Tue15Dec
Strategic reset framing the 2027 fundamental outlook, starting from $75.00.
- Tue9Feb
Critical Q4 print defining the FY27 earnings baseline, launching from $81.00.
- Fri30Apr
- Thu22Jul
Past
- Tue1Sep
Progress update on recent debt-funded acquisitions and balance sheet health, starting from $73.00.
- Sat15Aug
Actual outcome: Bear
Escalating trade policies and tariffs under the Trump administration raised concerns regarding the company's margin exposure and potential cost pressures. Without company-specific catalysts to offset these macro headwinds, the market priced in the negative impact on profitability, driving the stock below the $73.00 bear floor.
Evaluation of margin exposure to escalating trade policies and tariffs, anchored at $79.00.
- Thu23Jul
Actual outcome: Mixed · $74.60 at outcome
The stock experienced a muted 1.9% increase during the target window, as the actual Q2 earnings report was not released until July 30. Without the anticipated catalyst materializing by the outcome date, price action remained flat and ambiguous, failing to make a definitive move toward either the $79 bull target or the $68 bear floor.
Q2 earnings print evaluating H2 visibility, measured from the $74.00 support level.
- Mon15Jun
Actual outcome: Mixed · $78.82 at outcome
MTX shares remained flat between the event and outcome dates, as no material company-specific updates regarding Q2 pricing power or market share concerns emerged during the observation window. Without new fundamental catalysts to confirm either the bull or bear case, the stock traded sideways, reflecting market indecision.
Assessment of Q2 pricing power amidst global input cost volatility, evaluated from the $79.00 base price.
- Fri1May
Actual outcome: Bear · $71.94 at outcome
Minerals Technologies reported Q1 2026 EPS of $1.17, exactly matching consensus estimates. With the stock trading near its 52-week high heading into the print, the lack of an earnings beat or stronger growth signals failed to support the rich valuation, leading to a 5.3% pullback over the following week.
Q1 2026 results will be the first clean quarter after the Q1 2025 loss and the recent debt-funded acquisition, with the stock already at $73.02 near its 52-week high. A solid print that confirms stable volumes in paper, construction, and energy-linked end markets and shows margin traction from pricing and mix could nudge shares toward $74.50, but any sign of slower growth or weaker margins against a rich valuation could quickly knock the stock back toward $74.50.
- Wed1Apr
Actual outcome: Bull · $80.65 at outcome
The anticipated downside risk of a debt-funded acquisition did not materialize during the period. Instead, Minerals Technologies received an analyst upgrade to a 'Buy' rating driven by growing optimism around its earnings prospects, which supported the stock's strength and pushed shares toward the bull target.
Given the current high EV/EBITDA and modest debt load, any large, debt-funded acquisition could lead to an asymmetric downside risk, especially if growth integration is slow. This catalyst is modeled as a downside risk event.
- Fri20Feb
Actual outcome: Bull · $73.47 at outcome
The catalyst delivered a strong bull outcome, with the stock surging to $72.97, significantly clearing the $68.50 bull target. This price action indicates that MTX's Q4 2025 results and initial 2026 guidance strongly exceeded market expectations. The results likely confirmed a successful recovery from the Q1 2025 loss and demonstrated robust stabilization and growth in the high-margin PCC product segment, validating the bull case thesis.
Release of Q4 2025 financial results and initial outlook for fiscal year 2026. Market focus on recovery from the Q1 2025 loss and stabilization of high-margin product growth (PCC).
